BioPharma Credit PLC (LON:BPCR)
London
· Delayed Price · Currency is GBP · Price in USD 0.8560
+0.0020 (0.23%)
Apr 28, 2025, 4:35 PM BST
BioPharma Credit Revenue
In the year 2024, BioPharma Credit had annual revenue of $150.03M USD with 10.53% growth. BioPharma Credit had revenue of $70.89M in the half year ending December 31, 2024, a decrease of -50.16%.
Revenue
$150.03M
Revenue Growth
+10.53%
P/S Ratio
6.03
Revenue / Employee
n/a
Employees
n/a
Market Cap
722.04M GBP
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| HSBC Holdings | 48.93B |
| London Stock Exchange Group | 8.86B |
| Lloyds Banking Group | 17.51B |
| Barclays | 24.25B |
| 3i Group | 4.29B |
| NatWest Group | 14.34B |
| Standard Chartered | 15.17B |
| Prudential | 9.79B |